Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

The antibody response to oligodendrocyte specific protein in multiple sclerosis.

Aslam M, Kalluri SR, Cepok S, Kraus V, Buck D, Srivastava R, Hemmer B.

J Neuroimmunol. 2010 Apr 15;221(1-2):81-6. doi: 10.1016/j.jneuroim.2010.02.008. Epub 2010 Mar 17.

PMID:
20236710
2.

A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic.

Bronstein JM, Lallone RL, Seitz RS, Ellison GW, Myers LW.

Neurology. 1999 Jul 13;53(1):154-61.

PMID:
10408552
3.

Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve.

Bajramovic JJ, Brok HP, Ouwerling B, Jagessar SA, van Straalen L, Kondova I, Bauer J, Amor S, 't Hart BA, Ben-Nun A.

Eur J Immunol. 2008 May;38(5):1452-64. doi: 10.1002/eji.200737164.

4.
5.

Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice.

Stevens DB, Chen K, Seitz RS, Sercarz EE, Bronstein JM.

J Immunol. 1999 Jun 15;162(12):7501-9.

6.

Cerebrospinal fluid immunoglobulin G promotes oligodendrocyte progenitor cell migration.

Tiwari-Woodruff SK, Myers LW, Bronstein JM.

J Neurosci Res. 2004 Aug 1;77(3):363-6.

PMID:
15248292
7.

[The study of anti-oligodendrocyte antibody in sera, and CSF of patients with multiple sclerosis].

Hirayama M, Kawai K, Iida M.

Rinsho Shinkeigaku. 1990 Mar;30(3):262-5. Japanese.

PMID:
2364627
8.

Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).

Kaushansky N, Eisenstein M, Oved JH, Ben-Nun A.

Int Immunol. 2008 Nov;20(11):1439-49. doi: 10.1093/intimm/dxn099. Epub 2008 Sep 18.

PMID:
18801757
9.

Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.

Lily O, Palace J, Vincent A.

Brain. 2004 Feb;127(Pt 2):269-79. Epub 2003 Dec 8.

PMID:
14662514
10.

IgG reactivity against citrullinated myelin basic protein in multiple sclerosis.

de Seze J, Dubucquoi S, Lefranc D, Virecoulon F, Nuez I, Dutoit V, Vermersch P, Prin L.

J Neuroimmunol. 2001 Jul 2;117(1-2):149-55.

PMID:
11431015
11.
12.

T-cell responses to oligodendrocyte-specific protein in multiple sclerosis.

Vu T, Myers LW, Ellison GW, Mendoza F, Bronstein JM.

J Neurosci Res. 2001 Nov 1;66(3):506-9.

PMID:
11746369
13.

Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.

Archelos JJ, Trotter J, Previtali S, Weissbrich B, Toyka KV, Hartung HP.

Ann Neurol. 1998 Jan;43(1):15-24.

PMID:
9450764
14.

Homogeneity of active demyelinating lesions in established multiple sclerosis.

Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.

Ann Neurol. 2008 Jan;63(1):16-25. doi: 10.1002/ana.21311.

PMID:
18232012
15.

Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission.

Cid C, Regidor I, Alcázar A.

J Neuroimmunol. 2007 Mar;184(1-2):223-6. Epub 2006 Dec 11.

PMID:
17161872
16.

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.

Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.

Brain. 2007 May;130(Pt 5):1206-23. Epub 2007 Apr 17.

PMID:
17439988
17.

T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.

Sun J, Link H, Olsson T, Xiao BG, Andersson G, Ekre HP, Linington C, Diener P.

J Immunol. 1991 Mar 1;146(5):1490-5.

PMID:
1899688
18.

Oligodendrocyte-binding antibodies in multiple sclerosis: 125I-protein A studies.

Steck AJ, Regli F.

Neurology. 1980 May;30(5):540-2.

PMID:
7189260
19.

High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease.

Agius MA, Kirvan CA, Schafer AL, Gudipati E, Zhu S.

Acta Neurol Scand. 1999 Sep;100(3):139-47.

PMID:
10478576
20.

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.

Brain. 2007 May;130(Pt 5):1194-205. Epub 2007 Feb 4.

PMID:
17282996

Supplemental Content

Support Center